Accounting Estimates Based on Assumptions Regarding COVID-19
First written in FY2020. 5 of 9 entries say "Restated". Latest entry: FY2023.
- FY2023DroppedAnnual report
「Our group's consolidated financial statements are prepared in accordance with accounting standards generally accepted as fair and appropriate in Japan. In preparing these consolidated financial statements, we use estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, but figures based on these estimates and assumptions may differ from actual results.」
The accounting estimates based on assumptions concerning when the novel coronavirus disease would subside and other matters, which had been disclosed separately through the previous fiscal year, are not presented as a separate topic among the significant accounting estimates for the current consolidated fiscal year. - FY2022RestatedAnnual report
「Although the impact of the novel coronavirus disease will continue during the fiscal year ending March 2023, we assume that society and the economy will seek to coexist with it.」
The company uses in its estimates for impairment and the recoverability of deferred tax assets the assumption that the infection's impact will continue during the fiscal year ending March 2023, while society and the economy will seek to coexist with it. - FY2022-Q3RestatedAnnual report
「There have been no material changes in the assumptions described in the previous fiscal year's securities report, under "Notes (Significant Accounting Estimates)," including assumptions concerning the impact of the novel coronavirus disease and when it will subside.」
The company explains that there have been no material changes from the previous consolidated fiscal year in the assumptions used for accounting estimates, including assumptions concerning the impact of the novel coronavirus disease and when it will subside. - FY2022-Q2RestatedAnnual report
「There have been no material changes in the assumptions described in the previous fiscal year's securities report, under "Notes (Significant Accounting Estimates)," including assumptions concerning the impact of the novel coronavirus disease and when it will subside.」
The company explains that there have been no material changes in the assumptions used for accounting estimates, including assumptions concerning the impact of the novel coronavirus disease and when it will subside. - FY2021WorsenedAnnual report
「The impact of the novel coronavirus disease involves a high degree of estimation uncertainty, and there is a risk of further declarations of a state of emergency, operating restrictions based on such declarations and a downturn in economic activity. If orders received in the kimono-related business fall materially below the assumptions used in the estimates, new asset groups may show indications of impairment. In addition, if undiscounted operating cash flow falls below the carrying amount of an asset group's fixed assets, an impairment loss may arise in the next consolidated fiscal year.」
The company states that the impact of the infection involves a high degree of estimation uncertainty and specifically describes the possibility that an impairment loss could arise in the next consolidated fiscal year due to additional declarations of a state of emergency and operating restrictions. - FY2021-Q3RestatedAnnual report
「Our group makes accounting estimates, including assessing the recoverability of deferred tax assets and determining impairment losses, on the assumption that although the impact of the coronavirus disease will continue during the fiscal year ending March 2022 because the spread of the novel coronavirus disease may not subside and repeated declarations of a state of emergency are a concern, net sales will gradually recover. We have changed some of the assumptions described in the previous fiscal year's securities report, under "Additional Information (Accounting Estimates Related to the Spread of the Novel Coronavirus Disease)," including assumptions concerning when the novel coronavirus disease will subside.」
The company continues to use revised assumptions for its accounting estimates, assuming that the infection's impact will continue during the fiscal year ending March 2022 while expecting net sales to gradually recover. - FY2021-Q2WorsenedAnnual report
「Our group makes accounting estimates, including assessing the recoverability of deferred tax assets and determining impairment losses, on the assumption that although the impact of the coronavirus disease will continue during the fiscal year ending March 2022, including uncertainty over whether Coming-of-Age ceremonies will be held as usual, net sales will gradually recover. We have changed some of the assumptions described in the previous fiscal year's securities report, under "Additional Information (Accounting Estimates Related to the Spread of the Novel Coronavirus Disease)," including assumptions concerning when the novel coronavirus disease will subside.」
The company changed some of its previous assumptions concerning when the infection would subside and other matters, and reflected in its accounting estimates that the infection's impact would continue in the fiscal year ending March 2022 and that it was uncertain whether Coming-of-Age ceremonies would be held as usual. - FY2021-Q1RestatedAnnual report
「There have been no material changes in the assumptions described in the previous fiscal year's securities report, under "Additional Information (Accounting Estimates Related to the Spread of the Novel Coronavirus Disease)," including assumptions concerning how the novel coronavirus disease will spread and when it will subside.」
The company explains that there have been no material changes from the previous consolidated fiscal year in the assumptions used for accounting estimates, including how the infection will spread and when it will subside. - FY2020First statedAnnual report
「The company makes accounting estimates, including assessing the recoverability of deferred tax assets and determining impairment losses, on the assumption that the infection will gradually subside by March 2021 and that net sales will begin to recover.」
The company reflects in its estimates of the recoverability of deferred tax assets and impairment losses the assumption that the infection will subside and net sales will recover by March 2021.